Tag: EuroPCR 2022

AI holds “huge potential” for cardiology

The potential to utilise artificial intelligence (AI) or machine learning in cardiology is “huge”,...

First-in-human results of Captis embolic protection device presented at EuroPCR 2022

Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...

New consensus statement will take into account latest clinical trial evidence on renal denervation

 A new consensus statement—in development from the European Society of Cardiology (ESC) and the ...

EuroPCR 2022: “Clear need” for transcatheter options for tricuspid regurgitation

 “At the moment, tricuspid is the valve where most things are happening,” says Hendrik Treede (U...

EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...

EuroPCR 2022: Robotic PCI changes the cath lab environment

 Robotic-assisted percutaneous coronary intervention (PCI) has the potential to offer a raft of ...

EuroPCR 2022: CLASP TR among the trials to watch in the tricuspid space

 Transcatheter tricuspid valve repair potentially offers a “less risky” option for patients with...

EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...

EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI

 Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolution of transcatheter...

EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...

EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...

EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...

EuroPCR 2022: Sham controlled trials have “revitalised” interest in renal denervation

 “Renal denervation has travelled a very storied path over the last 10–15 years,” David Kandzari...

Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...

EuroPCR 2022 hears new data on robotic PCI

New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...

EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...